For citations:
Burtsev E.A., Evseev D.A., Gaziev I.R., Lebedeva L.L., Skobeev D.A., Osipova D.S., Bronin G.O., Maschan M.A. The use of BRAF-inhibitors as monotherapy and in combination with cytosine arabinoside and 2-chloro-2’deoxyadenosine in pediatric patients with different forms of Langerhans cell histiocytosis. Russian Journal of Pediatric Hematology and Oncology. 2023;10(4):13-24. (In Russ.) https://doi.org/10.21682/2311-1267-2023-10-4-13-24